Cargando…

DOAC drug interactions management resource

Detalles Bibliográficos
Autores principales:	Chadha, Ayush, Guirguis, Micheal, Bungard, Tammy J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Research and Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647398/ https://www.ncbi.nlm.nih.gov/pubmed/36386604 http://dx.doi.org/10.1177/17151635221116100

Ejemplares similares

The Problem With Predictions: A Cautionary Tale of Empirically Adjusting Apixaban Dosing With Carbamazepine
por: Chadha, Ayush, et al.
Publicado: (2022)

Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice
por: Ferri, Nicola, et al.
Publicado: (2022)

Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
por: Hardy, Michael, et al.
Publicado: (2022)

Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests
por: Favresse, Julien, et al.
Publicado: (2018)

Adverse Events of DOACs in Children
por: Bosch, Alessandra, et al.
Publicado: (2022)

DOAC in COVID-19: Yes or No?
por: Schutgens, Roger E.
Publicado: (2020)

DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation
por: Margetić, Sandra, et al.
Publicado: (2022)

Optimization of DOAC management services in a centralized anticoagulation clinic
por: Sylvester, Katelyn W., et al.
Publicado: (2022)

DOACs – advances and limitations in real world
por: Lee, Lai Heng
Publicado: (2016)

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
por: Burnett, Allison E., et al.
Publicado: (2016)

Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review
por: Sunkara, Tagore, et al.
Publicado: (2016)

The myths behind DOAC measurement: Analyses of prescribing information from different regulatory bodies and a call for harmonization
por: Gosselin, Robert C., et al.
Publicado: (2022)

Drug Use Evaluation of Direct Oral Anticoagulants (DOACs) in Patients With Advanced Cirrhosis
por: Jarboe, Lindsey, et al.
Publicado: (2022)

Bariatric Surgery can Lower the Efficacy of DOACs
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2020)

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021)

Management of acute venous thromboembolism among a cohort of patients discharged directly from the emergency department
por: Bungard, Tammy J, et al.
Publicado: (2018)

New Direct Oral Anticoagulants (DOAC) and Their Use Today
por: Schwarb, Heike, et al.
Publicado: (2016)

DOACs and “newer” hemophilia therapies in COVID‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

DOACs and rheumatic valvulopathy: always a red light?
por: Rochira, Carla, et al.
Publicado: (2023)

Spontaneous rectal sheath bleed while on DOAC anticoagulation
por: de Courcy, Louis, et al.
Publicado: (2023)

Carbamazepine Induction Impacting Apixaban Concentrations: A Case Report
por: Bungard, Tammy J., et al.
Publicado: (2020)

Plasma Drug Values of DOACs in Patients Presenting with Gastrointestinal Bleeding: A Prospective Observational Study
por: Bozic, Dorotea, et al.
Publicado: (2023)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
por: Doucette, Kimberley, et al.
Publicado: (2020)

DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease
por: Dummer, Kirsten B., et al.
Publicado: (2023)

Management of Traumatic Brain Injury in Patients with DOAC Therapy–Are the “New” Oral Anticoagulants Really Safer?
por: Antoni, Anna, et al.
Publicado: (2022)

Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care
por: Bungard, Tammy J, et al.
Publicado: (2009)

The relationship between DOAC levels and clinical outcomes: The measures tell the tale
por: Toorop, Myrthe M. A., et al.
Publicado: (2020)

Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease
por: Rogula, Sylwester, et al.
Publicado: (2022)

P1665: USE OF DOACS IN THE MANAGEMENT OF UPPER EXTREMITY DEEP VENOUS THROMBOSIS; A SYSTEMATIC REVIEW
por: Ge, Sarah, et al.
Publicado: (2023)

Peri-Procedural Management of Direct-Acting Oral Anticoagulants (DOACs) in Transcatheter Miniaturized Leadless Pacemaker Implantation
por: Regoli, François Diederik, et al.
Publicado: (2023)

Performance Characteristics of DOAC Dipstick in Determining Direct Oral Anticoagulants in Urine
por: Harenberg, Job, et al.
Publicado: (2021)

Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?
por: Palmirotta, Raffaele
Publicado: (2021)

Prescription of DOACs in Patients with Atrial Fibrillation at Different Stages of Renal Insufficiency
por: Hahn, Kai, et al.
Publicado: (2023)

DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives
por: Langenaeken, Tom, et al.
Publicado: (2023)

DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices
por: Buka, Richard J., et al.
Publicado: (2022)

Which Renal Function Equation Should Be Used for Prescribing DOACs in Patients With Atrial Fibrillation?
por: Wang, Yilong, et al.
Publicado: (2022)

DOACs in patients with brain cancers: promising but still a long way to go
por: Giustozzi, Michela, et al.
Publicado: (2022)

Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
por: Leung, Timothy S, et al.
Publicado: (2015)

Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribing
por: Kampouraki, Emmanouela, et al.
Publicado: (2020)

DOAC in the treatment of cancer-associated venous thromboembolism: a retrospective cohort study beyond the guidelines
por: Cominacini, Mattia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a5npjpo1kck7garv1804mm8ech